Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;31(3):185-92.
doi: 10.1007/s40266-014-0158-4.

Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review

Mohammed Saji Salahudeen  1 , Stephen B Duffull, Prasad S Nishtala
Affiliations

Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review

Mohammed Saji Salahudeen et al. Drugs Aging. 2014 Mar.

Abstract

Background: Medicines with anticholinergic properties increase the risks of functional and cognitive decline, morbidity and mortality, institutionalization and length of hospital stay in older people. It is postulated that minimizing anticholinergic burden should result in improved short-term memory, confusion and delirium, and may improve the quality of life and daily functioning of older people.

Objective: The objective of this systematic review was to investigate the impact of discontinuing medicines with anticholinergic properties on cognitive outcomes in older people.

Design: A comprehensive systematic search was performed to identify relevant studies, using Medline, Embase, International Pharmaceutical Abstracts (IPA), PsycINFO, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Central Register of Controlled Trials, from 1946 to July 2013. The critical appraisal was performed by two independent reviewers, and the data were extracted onto standardized forms. The primary outcome of interest was evaluation of cognitive changes in older people after anticholinergic discontinuation, measured using cognitive assessment scales. Meta-analysis was not conducted, because of the heterogeneity of the study designs, interventions and outcome measures.

Results: The primary electronic literature search identified a total of 475 records in the six different databases. On the basis of full-text analysis, only four studies met the inclusion criteria. The review found two randomized control trials and two prospective cohort studies that met the inclusion criteria. Only the cohort studies demonstrated improvement of cognitive performance after discontinuation of anticholinergic medicines.

Conclusions: The impact of anticholinergic discontinuation on cognitive function remains poorly researched and poorly understood. A larger sample size, longer duration of follow-up and better methods of assessing anticholinergic-induced cognitive impairment are warranted.

PubMed Disclaimer

References

    1. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):314-9 - PubMed
    1. J Am Geriatr Soc. 2011 May;59(5):875-80 - PubMed
    1. Expert Rev Clin Pharmacol. 2010 Jul;3(4):441-52 - PubMed
    1. Arch Intern Med. 2008 Mar 10;168(5):508-13 - PubMed
    1. Am J Geriatr Psychiatry. 2013 Aug;21(8):785-93 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources